Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PARD6BP1 (PARD6B Pseudogene 1) is classified as a pseudogene in the human genome. Unlike protein-coding genes, pseudogenes are typically non-functional and do not produce proteins. There is no evidence in the literature or genetic databases of this pseudogene being involved in therapeutic interventions, drug targeting, or disease biology. It is distinct from the functional gene PARD6B, which encodes a cell polarity regulator protein involved in cell division and is implicated in cancer biology[1][4][5][7]. Be careful not to confuse PARD6BP1 (pseudogene) with PARD6B (protein-coding gene). The functional gene PARD6B is implicated in cell polarity, proliferation, and cancer progression, but PARD6BP1 has no described biological activity or therapeutic relevance based on current sources[1][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PARD6B Pseudogene 1 (PARD6BP1).